The Global Atopic Dermatitis Market was worth USD 6.54 billion in 2021. It is expected for industry to register a CAGR of 13.87% over the forecast duration, thereby amassing a valuation of USD 16.23 billion by end of the assessment timeframe.
Atopic dermatitis is a chronic skin condition that causes itchiness, dryness, and inflammation on the skin. It may also lead to skin discoloration if not treated on time. This ailment can occur in both children and adults. A wide array of reasons is responsible for the occurrence of atopic dermatitis including the exposure to irritants present in certain products like soaps, shampoos, and detergents among others. Apart from that, allergens and harsh environmental conditions may also cause this disease.
Get Sample of Report@ https://brandessenceresearch.com/downloadSample/PostId/1519
Global Atopic Dermatitis Market Outlook (2022-2029)
The growing prevalence of this disease along with the escalating demand for early diagnosis and treatment of atopic dermatitis are primarily augmenting the outlook of this business vertical.
Furthermore, rising R&D investments in the field, increasing healthcare expenditure across various nations, together with surging clinical research activities worldwide are adding momentum to the progression of this marketplace.
Also, the presence of favourable medical reimbursement scenario across developed countries is another growth catalyst for this industry sphere.
The rapidly evolving healthcare infrastructure, rising awareness about atopic dermatitis among the masses, coupled with growing focus of research organizations and pharmaceutical companies to develop efficient treatment therapeutics for this ailment are aiding market expansion.
On the contrary, the progression of Global Atopic Dermatitis Market is being hindered by the high cost of anti-atopic dermatitis therapeutics along with the rising instances of patent expiry of products.
The global health crisis triggered by the outbreak of the COVID-19 pandemic had a negative influence on the growth trajectory of this industry. Strict lockdown impositions, fear of virus contraction, and overcrowded healthcare centers with COVID-19 patients, restricted the masses from visiting a healthcare facility to have their check-ups and treatments done until it was a case of an emergency. Dermatological disorders like atopic dermatitis generally come under non-emergency disease and therefore do not need immediate attention. During the pandemic era, healthcare providers had to emphasize treating the COVID-19 infected patients while attending the people who required critical care. This pushed them to postpone the consultation or treatment of people having non-serious health conditions. This in turn slowed down the progression of this business vertical over the pandemic period.
Competitive Hierarchy
The prominent players characterizing the competitive terrain of the Global Atopic Dermatitis Market are Novartis International AG, Astellas Pharma Inc., Pfizer Inc., Sanofi S.A., Regeneron Pharmaceuticals Inc., Valeant Pharmaceuticals International Inc., Anacor Pharmaceuticals Inc., Bristol-Myers Squibb, Meda Pharmaceuticals, Galderma S.A., Allergan Plc., LEO Pharma, Mylan, Bayer HealthCare, and Encore Dermatology.
These players are striving hard to enhance their overall market position. They are participating in the formulation of various growth inducing strategies such as mergers & acquisitions, collaborations, partnerships, and new product launches, among others to witness robust financial gains and emerge as global leaders.
Segmental Outlook
By Drug Class
- Biologics
- Corticosteroids
- Calcineurin Inhibitors
- PDE4 Inhibitors
- Others
By Disease Indication
- Atopic Dermatitis
- Contact Dermatitis
- Other
By Distribution Channel
- Hospital Pharmacy
- Retail Pharmacy
- Online Pharmacy
Get Methodology @ https://brandessenceresearch.com/requestMethodology/PostId/1519
Region-Wise Outlook
Which is the leading region in the Global Atopic Dermatitis Market?
North America is reckoned to lead the market in terms of volume share over the forecast duration. This is attributable to the increasing patient pool diagnosed with the target disease, influx of noteworthy players, and presence of favorable medical reimbursement scenario.
How is Asia Pacific performing in this industry?
Asia Pacific is slated to amass notable gains over 2022-2029 owing to the rapidly evolving healthcare infrastructure in this region, rising awareness about atopic dermatitis among the masses, and escalating demand for biologics in the dermatological treatment sector.
Category-Wise Outlook
Which is the most dominant drug class segment in this business vertical?
The biologics sector is currently dominating the market in terms of volume share. This is ascribed to the efficacy of biologics-based therapeutics in treating dermatological disorders.
Which is the fastest growing distribution channel segment in this marketplace?
The online pharmacy segment has emerged as one of the fastest growing segments in this industry sphere due to the widespread internet proliferation and increasing adoption of smart devices across the globe.
Comparing the historical outlook and ongoing trends of this market
This market vertical is being positively impacted by a wide array of growth propellants which have emerged over the stipulated timeline.
There has been a surging pervasiveness of atopic dermatitis across the globe. This disease is predominantly triggered by harsh climatic conditions, exposure to allergens and irritants, genetic factors, age, lifestyle habits, and dietary trends. Mostly, the disease occurs at an early age, but the symptoms turn severe with age. In 2017, the World Health Organization revealed that around 900 million people worldwide were diagnosed with atopic dermatitis. These factors are stimulating the overall dynamics of this business sphere.
Medical research organizations along with biotech and pharmaceutical companies have been up their R&D activities with an aim to create effective therapeutics to treat this disorder. It is worth noting that the use of biologics-based drugs has proven to be quite efficient in treating dermatological disorders. As of now, one biologic product has received approval from regulatory authorities and is being used in the treatment of atopic dermatitis. This in turn is adding traction to the development of this market.
On Special Requirement Atopic Dermatitis Market Report is also available for below region:
North America
- U.S, Canada
- Germany, France, U.K., Italy, Spain, Sweden, Netherland, Turkey, Switzerland, Belgium, Rest of Europe
Asia-Pacific
- South Korea, Japan, China, India, Australia, Philippines, Singapore, Malaysia, Thailand, Indonesia, Rest Of APAC
Latin America
- Mexico, Colombia, Brazil, Argentina, Peru, Rest of Latin America
Middle East and Africa
- Saudi Arabia, UAE, Egypt, South Africa, Rest Of MEA
Purchase Copy of Report @ https://brandessenceresearch.com/Checkout?report_id=1519
Major Developments
In January 2022, CIBNQ0 a drug developed by Pfizer for the treatment of adults diagnosed with severe atopic dermatitis received approval from the FDA.
Related Reports:
- Home Diagnostics Market Size, Analysis, Share, Research, Business Growth and Forecast to 2029
- Orthokeratology Lens Market Expected to Flourish in Coming Years says Brandessence Market Research
- U.S. Medical Marijuana Market Share, Size, Regional insights from (2022-2029)
- U.S. Ambulatory Surgical Centers Market by Center Type, Surgery Type, Owner Type and Key Geographical Regions: Industry Trends and Global Forecasts, 2022-2029
- Healthcare IT Market – Industry Trends and Forecast to 2029
- U.S. Telemedicine Market Size (2022-2029) Share, Industry Trends, Growth, Challenges, and Forecast: Brandessence Market Research
- Artificial Intelligence (AI) in Medical Imaging Market Is Expected to Boom – Siemens Healthineers, General Electric, Koninklijke Philips, IBM.
- Global Exoskeleton Market: Industry Trends & Outlook 2023 says Brandessence Market Research
- Endoluminal Suturing Devices Market Expected to Flourish in Coming Years says Brandessence Market Research
- Cleanroom Consumables Market Opportunities, Regional Trends and Industry Analysis 2022-2029 | Berkshire Corporation, Valutek, Texwipe, Nitritex Ltd. | Brandessence Market Research
- Global Construction Equipment Rental Market is projected to be valued at USD 162.23 Billion by 2025, growing at a CAGR of 4.75%: Brandessence Market Research
- Solar Control Window Film Market to be Worth ~$1,203.1 Mn by 2029: Brandessence Market Research
- Biscuit Mix Market Share and Growth Factors Impact Analysis 2022 – 2029 | Report by Brandessence Market Research
- Battery Management System Market size is expected to reach ~USD 14 billion by 2028 | Brandessence Market Research
- IoT In Healthcare Market Size Growing at 19.20 % CAGR, Set to Reach USD 388.18 Billion by 2027 says Brandessence Market Research
- Healthcare Payer Services Market Forecast 2022-2029: Demand, Business Growth, Opportunity, Application, Cost, Sales, Service, End-Use, Size, Top Manufacturers Analysis – Cognizant, EXL, HGS Ltd., Accenture | Brandessence Market Research
- Global Thermoplastics Market Size/Share Worth USD 41.89 Billion by 2029 at a 6.79 % CAGR: AI Market Report (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth, Growth Rate, Value)
- Amyotrophic Lateral Sclerosis Treatment Market Size to Hit USD 436.17 Million by 2027 at 5.52% CAGR Reported by Brandessence Market Research
- Autism Spectrum Disorder Market size is projected to grow at a CAGR of +8.5%
- Treasury Software Market Projected to Reach CAGR of +11% Forecast by 2029 says Brandessence Market Research
Brandessence Market Research & Consulting Pvt ltd.
Brandessence Market Research publishes market research reports & business insights produced by highly qualified and experienced industry analysts. Our research reports are available in a wide range of industry verticals including aviation, food & beverage, healthcare, ICT, Construction, Chemicals and lot more. Brand Essence Market Research report will be best fit for senior executives, business development managers, marketing managers, consultants, CEOs, CIOs, COOs, and Directors, governments, agencies, organizations and Ph.D. Students. We have a delivery center in Pune, India and our sales office is in London.
